Table of Content

1 Study Coverage
1.1 Biosuperior Product Introduction
1.2 Market by Type
1.2.1 Global Biosuperior Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 G-CSF Biobetters
1.2.3 Insulin Biobetters
1.2.4 Erythropoietin Biobetters
1.2.5 Monoclonal Antibodies Biobetters
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biosuperior Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Genetic Disease
1.3.5 Neurological Disorders
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biosuperior Sales Estimates and Forecasts 2018-2029
2.2 Global Biosuperior Revenue by Region
2.2.1 Global Biosuperior Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Biosuperior Revenue by Region (2018-2024)
2.2.3 Global Biosuperior Revenue by Region (2024-2029)
2.2.4 Global Biosuperior Revenue Market Share by Region (2018-2029)
2.3 Global Biosuperior Sales Estimates and Forecasts 2018-2029
2.4 Global Biosuperior Sales by Region
2.4.1 Global Biosuperior Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Biosuperior Sales by Region (2018-2024)
2.4.3 Global Biosuperior Sales by Region (2024-2029)
2.4.4 Global Biosuperior Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Biosuperior Sales by Manufacturers
3.1.1 Global Biosuperior Sales by Manufacturers (2018-2024)
3.1.2 Global Biosuperior Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biosuperior in 2022
3.2 Global Biosuperior Revenue by Manufacturers
3.2.1 Global Biosuperior Revenue by Manufacturers (2018-2024)
3.2.2 Global Biosuperior Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Biosuperior Revenue in 2022
3.3 Global Key Players of Biosuperior, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Biosuperior Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biosuperior Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biosuperior, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biosuperior, Product Offered and Application
3.8 Global Key Manufacturers of Biosuperior, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biosuperior Sales by Type
4.1.1 Global Biosuperior Historical Sales by Type (2018-2024)
4.1.2 Global Biosuperior Forecasted Sales by Type (2024-2029)
4.1.3 Global Biosuperior Sales Market Share by Type (2018-2029)
4.2 Global Biosuperior Revenue by Type
4.2.1 Global Biosuperior Historical Revenue by Type (2018-2024)
4.2.2 Global Biosuperior Forecasted Revenue by Type (2024-2029)
4.2.3 Global Biosuperior Revenue Market Share by Type (2018-2029)
4.3 Global Biosuperior Price by Type
4.3.1 Global Biosuperior Price by Type (2018-2024)
4.3.2 Global Biosuperior Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Biosuperior Sales by Application
5.1.1 Global Biosuperior Historical Sales by Application (2018-2024)
5.1.2 Global Biosuperior Forecasted Sales by Application (2024-2029)
5.1.3 Global Biosuperior Sales Market Share by Application (2018-2029)
5.2 Global Biosuperior Revenue by Application
5.2.1 Global Biosuperior Historical Revenue by Application (2018-2024)
5.2.2 Global Biosuperior Forecasted Revenue by Application (2024-2029)
5.2.3 Global Biosuperior Revenue Market Share by Application (2018-2029)
5.3 Global Biosuperior Price by Application
5.3.1 Global Biosuperior Price by Application (2018-2024)
5.3.2 Global Biosuperior Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Biosuperior Market Size by Type
6.1.1 US & Canada Biosuperior Sales by Type (2018-2029)
6.1.2 US & Canada Biosuperior Revenue by Type (2018-2029)
6.2 US & Canada Biosuperior Market Size by Application
6.2.1 US & Canada Biosuperior Sales by Application (2018-2029)
6.2.2 US & Canada Biosuperior Revenue by Application (2018-2029)
6.3 US & Canada Biosuperior Market Size by Country
6.3.1 US & Canada Biosuperior Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Biosuperior Sales by Country (2018-2029)
6.3.3 US & Canada Biosuperior Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Biosuperior Market Size by Type
7.1.1 Europe Biosuperior Sales by Type (2018-2029)
7.1.2 Europe Biosuperior Revenue by Type (2018-2029)
7.2 Europe Biosuperior Market Size by Application
7.2.1 Europe Biosuperior Sales by Application (2018-2029)
7.2.2 Europe Biosuperior Revenue by Application (2018-2029)
7.3 Europe Biosuperior Market Size by Country
7.3.1 Europe Biosuperior Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Biosuperior Sales by Country (2018-2029)
7.3.3 Europe Biosuperior Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Biosuperior Market Size
8.1.1 China Biosuperior Sales (2018-2029)
8.1.2 China Biosuperior Revenue (2018-2029)
8.2 China Biosuperior Market Size by Application
8.2.1 China Biosuperior Sales by Application (2018-2029)
8.2.2 China Biosuperior Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biosuperior Market Size by Type
9.1.1 Asia Biosuperior Sales by Type (2018-2029)
9.1.2 Asia Biosuperior Revenue by Type (2018-2029)
9.2 Asia Biosuperior Market Size by Application
9.2.1 Asia Biosuperior Sales by Application (2018-2029)
9.2.2 Asia Biosuperior Revenue by Application (2018-2029)
9.3 Asia Biosuperior Sales by Region
9.3.1 Asia Biosuperior Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Biosuperior Revenue by Region (2018-2029)
9.3.3 Asia Biosuperior Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biosuperior Market Size by Type
10.1.1 Middle East, Africa and Latin America Biosuperior Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Biosuperior Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Biosuperior Market Size by Application
10.2.1 Middle East, Africa and Latin America Biosuperior Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Biosuperior Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Biosuperior Sales by Country
10.3.1 Middle East, Africa and Latin America Biosuperior Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Biosuperior Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Biosuperior Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 F.Hoffmann-La Roche AG
11.1.1 F.Hoffmann-La Roche AG Company Information
11.1.2 F.Hoffmann-La Roche AG Overview
11.1.3 F.Hoffmann-La Roche AG Biosuperior Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 F.Hoffmann-La Roche AG Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 F.Hoffmann-La Roche AG Recent Developments
11.2 Merck and Co.
11.2.1 Merck and Co. Company Information
11.2.2 Merck and Co. Overview
11.2.3 Merck and Co. Biosuperior Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck and Co. Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck and Co. Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Biosuperior Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sanofi Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 SERVIER
11.4.1 SERVIER Company Information
11.4.2 SERVIER Overview
11.4.3 SERVIER Biosuperior Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 SERVIER Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 SERVIER Recent Developments
11.5 Porton Biopharma
11.5.1 Porton Biopharma Company Information
11.5.2 Porton Biopharma Overview
11.5.3 Porton Biopharma Biosuperior Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Porton Biopharma Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Porton Biopharma Recent Developments
11.6 Eli Lily and Company
11.6.1 Eli Lily and Company Company Information
11.6.2 Eli Lily and Company Overview
11.6.3 Eli Lily and Company Biosuperior Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Eli Lily and Company Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Eli Lily and Company Recent Developments
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Information
11.7.2 Novo Nordisk Overview
11.7.3 Novo Nordisk Biosuperior Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Novo Nordisk Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novo Nordisk Recent Developments
11.8 Biogen
11.8.1 Biogen Company Information
11.8.2 Biogen Overview
11.8.3 Biogen Biosuperior Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Biogen Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biogen Recent Developments
11.9 CSL Behring GmbH
11.9.1 CSL Behring GmbH Company Information
11.9.2 CSL Behring GmbH Overview
11.9.3 CSL Behring GmbH Biosuperior Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 CSL Behring GmbH Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CSL Behring GmbH Recent Developments
11.10 Teva
11.10.1 Teva Company Information
11.10.2 Teva Overview
11.10.3 Teva Biosuperior Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Teva Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Teva Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biosuperior Industry Chain Analysis
12.2 Biosuperior Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biosuperior Production Mode & Process
12.4 Biosuperior Sales and Marketing
12.4.1 Biosuperior Sales Channels
12.4.2 Biosuperior Distributors
12.5 Biosuperior Customers
13 Market Dynamics
13.1 Biosuperior Industry Trends
13.2 Biosuperior Market Drivers
13.3 Biosuperior Market Challenges
13.4 Biosuperior Market Restraints
14 Key Findings in The Global Biosuperior Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Biosuperior Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of G-CSF Biobetters
Table 3. Major Manufacturers of Insulin Biobetters
Table 4. Major Manufacturers of Erythropoietin Biobetters
Table 5. Major Manufacturers of Monoclonal Antibodies Biobetters
Table 6. Major Manufacturers of Others
Table 7. Global Biosuperior Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Biosuperior Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Biosuperior Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Biosuperior Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Biosuperior Revenue Market Share by Region (2018-2024)
Table 12. Global Biosuperior Revenue Market Share by Region (2024-2029)
Table 13. Global Biosuperior Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Biosuperior Sales by Region (2018-2024) & (K Units)
Table 15. Global Biosuperior Sales by Region (2024-2029) & (K Units)
Table 16. Global Biosuperior Sales Market Share by Region (2018-2024)
Table 17. Global Biosuperior Sales Market Share by Region (2024-2029)
Table 18. Global Biosuperior Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Biosuperior Sales Share by Manufacturers (2018-2024)
Table 20. Global Biosuperior Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Biosuperior Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Biosuperior, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Biosuperior Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Biosuperior Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Biosuperior by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosuperior as of 2022)
Table 26. Global Key Manufacturers of Biosuperior, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Biosuperior, Product Offered and Application
Table 28. Global Key Manufacturers of Biosuperior, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Biosuperior Sales by Type (2018-2024) & (K Units)
Table 31. Global Biosuperior Sales by Type (2024-2029) & (K Units)
Table 32. Global Biosuperior Sales Share by Type (2018-2024)
Table 33. Global Biosuperior Sales Share by Type (2024-2029)
Table 34. Global Biosuperior Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Biosuperior Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Biosuperior Revenue Share by Type (2018-2024)
Table 37. Global Biosuperior Revenue Share by Type (2024-2029)
Table 38. Biosuperior Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Biosuperior Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Biosuperior Sales by Application (2018-2024) & (K Units)
Table 41. Global Biosuperior Sales by Application (2024-2029) & (K Units)
Table 42. Global Biosuperior Sales Share by Application (2018-2024)
Table 43. Global Biosuperior Sales Share by Application (2024-2029)
Table 44. Global Biosuperior Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Biosuperior Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Biosuperior Revenue Share by Application (2018-2024)
Table 47. Global Biosuperior Revenue Share by Application (2024-2029)
Table 48. Biosuperior Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Biosuperior Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Biosuperior Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Biosuperior Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Biosuperior Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Biosuperior Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Biosuperior Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Biosuperior Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Biosuperior Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Biosuperior Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Biosuperior Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Biosuperior Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Biosuperior Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Biosuperior Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Biosuperior Sales by Country (2024-2029) & (K Units)
Table 63. Europe Biosuperior Sales by Type (2018-2024) & (K Units)
Table 64. Europe Biosuperior Sales by Type (2024-2029) & (K Units)
Table 65. Europe Biosuperior Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Biosuperior Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Biosuperior Sales by Application (2018-2024) & (K Units)
Table 68. Europe Biosuperior Sales by Application (2024-2029) & (K Units)
Table 69. Europe Biosuperior Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Biosuperior Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Biosuperior Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Biosuperior Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Biosuperior Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Biosuperior Sales by Country (2018-2024) & (K Units)
Table 75. Europe Biosuperior Sales by Country (2024-2029) & (K Units)
Table 76. China Biosuperior Sales by Type (2018-2024) & (K Units)
Table 77. China Biosuperior Sales by Type (2024-2029) & (K Units)
Table 78. China Biosuperior Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Biosuperior Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Biosuperior Sales by Application (2018-2024) & (K Units)
Table 81. China Biosuperior Sales by Application (2024-2029) & (K Units)
Table 82. China Biosuperior Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Biosuperior Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Biosuperior Sales by Type (2018-2024) & (K Units)
Table 85. Asia Biosuperior Sales by Type (2024-2029) & (K Units)
Table 86. Asia Biosuperior Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Biosuperior Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Biosuperior Sales by Application (2018-2024) & (K Units)
Table 89. Asia Biosuperior Sales by Application (2024-2029) & (K Units)
Table 90. Asia Biosuperior Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Biosuperior Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Biosuperior Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Biosuperior Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Biosuperior Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Biosuperior Sales by Region (2018-2024) & (K Units)
Table 96. Asia Biosuperior Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Biosuperior Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Biosuperior Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Biosuperior Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Biosuperior Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Biosuperior Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Biosuperior Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Biosuperior Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Biosuperior Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Biosuperior Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Biosuperior Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Biosuperior Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Biosuperior Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Biosuperior Sales by Country (2024-2029) & (K Units)
Table 110. F.Hoffmann-La Roche AG Company Information
Table 111. F.Hoffmann-La Roche AG Description and Major Businesses
Table 112. F.Hoffmann-La Roche AG Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. F.Hoffmann-La Roche AG Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. F.Hoffmann-La Roche AG Recent Developments
Table 115. Merck and Co. Company Information
Table 116. Merck and Co. Description and Major Businesses
Table 117. Merck and Co. Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Merck and Co. Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Merck and Co. Recent Developments
Table 120. Sanofi Company Information
Table 121. Sanofi Description and Major Businesses
Table 122. Sanofi Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Sanofi Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Sanofi Recent Developments
Table 125. SERVIER Company Information
Table 126. SERVIER Description and Major Businesses
Table 127. SERVIER Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. SERVIER Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. SERVIER Recent Developments
Table 130. Porton Biopharma Company Information
Table 131. Porton Biopharma Description and Major Businesses
Table 132. Porton Biopharma Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Porton Biopharma Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Porton Biopharma Recent Developments
Table 135. Eli Lily and Company Company Information
Table 136. Eli Lily and Company Description and Major Businesses
Table 137. Eli Lily and Company Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Eli Lily and Company Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Eli Lily and Company Recent Developments
Table 140. Novo Nordisk Company Information
Table 141. Novo Nordisk Description and Major Businesses
Table 142. Novo Nordisk Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Novo Nordisk Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Novo Nordisk Recent Developments
Table 145. Biogen Company Information
Table 146. Biogen Description and Major Businesses
Table 147. Biogen Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Biogen Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Biogen Recent Developments
Table 150. CSL Behring GmbH Company Information
Table 151. CSL Behring GmbH Description and Major Businesses
Table 152. CSL Behring GmbH Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. CSL Behring GmbH Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. CSL Behring GmbH Recent Developments
Table 155. Teva Company Information
Table 156. Teva Description and Major Businesses
Table 157. Teva Biosuperior Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. Teva Biosuperior Product Model Numbers, Pictures, Descriptions and Specifications
Table 159. Teva Recent Developments
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Biosuperior Distributors List
Table 163. Biosuperior Customers List
Table 164. Biosuperior Market Trends
Table 165. Biosuperior Market Drivers
Table 166. Biosuperior Market Challenges
Table 167. Biosuperior Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Biosuperior Product Picture
Figure 2. Global Biosuperior Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Biosuperior Market Share by Type in 2022 & 2029
Figure 4. G-CSF Biobetters Product Picture
Figure 5. Insulin Biobetters Product Picture
Figure 6. Erythropoietin Biobetters Product Picture
Figure 7. Monoclonal Antibodies Biobetters Product Picture
Figure 8. Others Product Picture
Figure 9. Global Biosuperior Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Biosuperior Market Share by Application in 2022 & 2029
Figure 11. Cancer
Figure 12. Diabetes
Figure 13. Genetic Disease
Figure 14. Neurological Disorders
Figure 15. Others
Figure 16. Biosuperior Report Years Considered
Figure 17. Global Biosuperior Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Biosuperior Revenue 2018-2029 (US$ Million)
Figure 19. Global Biosuperior Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 20. Global Biosuperior Revenue Market Share by Region (2018-2029)
Figure 21. Global Biosuperior Sales 2018-2029 ((K Units)
Figure 22. Global Biosuperior Sales Market Share by Region (2018-2029)
Figure 23. US & Canada Biosuperior Sales YoY (2018-2029) & (K Units)
Figure 24. US & Canada Biosuperior Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Europe Biosuperior Sales YoY (2018-2029) & (K Units)
Figure 26. Europe Biosuperior Revenue YoY (2018-2029) & (US$ Million)
Figure 27. China Biosuperior Sales YoY (2018-2029) & (K Units)
Figure 28. China Biosuperior Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Asia (excluding China) Biosuperior Sales YoY (2018-2029) & (K Units)
Figure 30. Asia (excluding China) Biosuperior Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Middle East, Africa and Latin America Biosuperior Sales YoY (2018-2029) & (K Units)
Figure 32. Middle East, Africa and Latin America Biosuperior Revenue YoY (2018-2029) & (US$ Million)
Figure 33. The Biosuperior Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 34. The Top 5 and 10 Largest Manufacturers of Biosuperior in the World: Market Share by Biosuperior Revenue in 2022
Figure 35. Global Biosuperior Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Global Biosuperior Sales Market Share by Type (2018-2029)
Figure 37. Global Biosuperior Revenue Market Share by Type (2018-2029)
Figure 38. Global Biosuperior Sales Market Share by Application (2018-2029)
Figure 39. Global Biosuperior Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Biosuperior Sales Market Share by Type (2018-2029)
Figure 41. US & Canada Biosuperior Revenue Market Share by Type (2018-2029)
Figure 42. US & Canada Biosuperior Sales Market Share by Application (2018-2029)
Figure 43. US & Canada Biosuperior Revenue Market Share by Application (2018-2029)
Figure 44. US & Canada Biosuperior Revenue Share by Country (2018-2029)
Figure 45. US & Canada Biosuperior Sales Share by Country (2018-2029)
Figure 46. U.S. Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 47. Canada Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 48. Europe Biosuperior Sales Market Share by Type (2018-2029)
Figure 49. Europe Biosuperior Revenue Market Share by Type (2018-2029)
Figure 50. Europe Biosuperior Sales Market Share by Application (2018-2029)
Figure 51. Europe Biosuperior Revenue Market Share by Application (2018-2029)
Figure 52. Europe Biosuperior Revenue Share by Country (2018-2029)
Figure 53. Europe Biosuperior Sales Share by Country (2018-2029)
Figure 54. Germany Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 55. France Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 56. U.K. Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 57. Italy Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 58. Russia Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 59. China Biosuperior Sales Market Share by Type (2018-2029)
Figure 60. China Biosuperior Revenue Market Share by Type (2018-2029)
Figure 61. China Biosuperior Sales Market Share by Application (2018-2029)
Figure 62. China Biosuperior Revenue Market Share by Application (2018-2029)
Figure 63. Asia Biosuperior Sales Market Share by Type (2018-2029)
Figure 64. Asia Biosuperior Revenue Market Share by Type (2018-2029)
Figure 65. Asia Biosuperior Sales Market Share by Application (2018-2029)
Figure 66. Asia Biosuperior Revenue Market Share by Application (2018-2029)
Figure 67. Asia Biosuperior Revenue Share by Region (2018-2029)
Figure 68. Asia Biosuperior Sales Share by Region (2018-2029)
Figure 69. Japan Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 70. South Korea Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 71. China Taiwan Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 72. Southeast Asia Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 73. India Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 74. Middle East, Africa and Latin America Biosuperior Sales Market Share by Type (2018-2029)
Figure 75. Middle East, Africa and Latin America Biosuperior Revenue Market Share by Type (2018-2029)
Figure 76. Middle East, Africa and Latin America Biosuperior Sales Market Share by Application (2018-2029)
Figure 77. Middle East, Africa and Latin America Biosuperior Revenue Market Share by Application (2018-2029)
Figure 78. Middle East, Africa and Latin America Biosuperior Revenue Share by Country (2018-2029)
Figure 79. Middle East, Africa and Latin America Biosuperior Sales Share by Country (2018-2029)
Figure 80. Brazil Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 81. Mexico Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 82. Turkey Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 83. Israel Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 84. GCC Countries Biosuperior Revenue (2018-2029) & (US$ Million)
Figure 85. Biosuperior Value Chain
Figure 86. Biosuperior Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed